AstraZeneca Expands Clinical Trial Network in Philippines
Health

AstraZeneca Expands Clinical Trial Network in Philippines

Pharmaceutical giant AstraZeneca is expanding its clinical trial network in the Philippines through a partnership with the healthcare arm of Ayala Group. This collaboration will facilitate the identification and preparation of additional hospitals for research and testing of new treatments.

This article requires PRO

This article is outside the free access window or is a special report. PRO unlocks it and the full archive.